Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden

This study evaluated potential of serum tumor markers to predict the incidence and intensity of pancreatic cancer metastasis as well as patient survival. Retrospective records from 905 patients and prospective data from 142 patients were collected from two high-volume institutions. The levels of eig...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Liu, Liang, Xu, Hua-Xiang, Wang, Wen-Quan, Wu, Chun-Tao, Xiang, Jin-Feng, Liu, Chen, Long, Jiang, Xu, Jin, Fu, De-Liang, Ni, Quan-Xing, Houchen, Courtney W., Postier, Russell G., Li, Min, Yu, Xian-Jun
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2016
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4868732/
https://ncbi.nlm.nih.gov/pubmed/26745601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6819
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk